RT Journal Article
SR Electronic
T1 Introduction into the Marseille geographical area of a mild SARS-CoV-2 variant originating from sub-Saharan Africa
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.12.23.20248758
DO 10.1101/2020.12.23.20248758
A1 Philippe Colson
A1 Anthony Levasseur
A1 Philippe Gautret
A1 Florence Fenollar
A1 Van Thuan Hoang
A1 Jeremy Delerce
A1 Idir Bitam
A1 Rachid Saile
A1 Mossaab Maaloum
A1 Abdou Padane
A1 Marielle Bedotto
A1 Ludivine Brechard
A1 Vincent Bossi
A1 Mariem Ben Khedher
A1 Hervé Chaudet
A1 Matthieu Million
A1 Hervé Tissot-Dupont
A1 Jean-Christophe Lagier
A1 Souleymane Mboup
A1 Pierre-Edouard Fournier
A1 Didier Raoult
YR 2020
UL http://medrxiv.org/content/early/2020/12/24/2020.12.23.20248758.abstract
AB BACKGROUND In Marseille, France, the COVID-19 incidence evolved unusually with several successive epidemic episodes. The second outbreak started in July, was associated with North Africa, and involved travelers and an outbreak on passenger ships. This suggested the involvement of a new viral variant.METHODS We sequenced the genomes from 916 SARS-CoV-2 strains from COVID-19 patients in our institute. The patients’ demographic and clinical features were compared according to the infecting viral variant.RESULTS From June 26th to August 14th, we identified a new viral variant (Marseille-1). Based on genome sequences (n=89) or specific qPCR (n=53), 142 patients infected with this variant were detected. It is characterized by a combination of 10 mutations located in the nsp2, nsp3, nsp12, S, ORF3a, ORF8 and N/ORF14 genes. We identified Senegal and Gambia, where the virus had been transferred from China and Europe in February-April as the sources of the Marseille-1 variant, which then most likely reached Marseille through Maghreb when French borders reopened. In France, this variant apparently remained almost limited to Marseille. In addition, it was significantly associated with a milder disease compared to clade 20A ancestor strains.CONCLUSION Our results demonstrate that SARS-CoV-2 can genetically diversify rapidly, its variants can diffuse internationally and cause successive outbreaks.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the French Government under the Investments for the Future programme managed by the National Agency for Research (ANR), Mediterranee-Infection 10-IAHU-03 and was also supported by Region Provence Alpes Cote d'Azur and European funding FEDER PRIMMI (Fonds Europeen de Developpement Regional-Plateformes de Recherche et d'Innovation Mutualisees Mediterranee Infection), FEDER PA 0000320 PRIMMI.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the ethical committee of the Mediterranee Infection Institute (2020-016-2). Access to the patients' biological and registry data issued from the hospital information system was approved by the data protection committee of Assistance Publique-Hopitaux de Marseille (APHM) and was recorded in the European General Data Protection Regulation registry under number RGPD/APHM 2019-73All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used in the present manuscript are available upon request